UBS AM’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.4M Buy
481,072
+133,545
+38% +$7.88M 0.01% 905
2025
Q1
$25.4M Buy
347,527
+28,027
+9% +$2.05M 0.01% 860
2024
Q4
$26.4M Buy
319,500
+28,330
+10% +$2.34M 0.01% 845
2024
Q3
$20.8M Buy
291,170
+3,584
+1% +$256K 0.01% 935
2024
Q2
$19.7M Buy
287,586
+117,352
+69% +$8.04M 0.01% 868
2024
Q1
$9.13M Sell
170,234
-3,942
-2% -$211K ﹤0.01% 1036
2023
Q4
$9.28M Sell
174,176
-7,814
-4% -$416K ﹤0.01% 1013
2023
Q3
$9.04M Buy
181,990
+68,513
+60% +$3.4M ﹤0.01% 990
2023
Q2
$6.43M Hold
113,477
﹤0.01% 1127
2023
Q1
$6.43M Sell
113,477
-7,450
-6% -$422K ﹤0.01% 1127
2022
Q4
$8.98M Buy
120,927
+3,934
+3% +$292K ﹤0.01% 980
2022
Q3
$6.97M Sell
116,993
-26,398
-18% -$1.57M ﹤0.01% 1088
2022
Q2
$8.05M Buy
143,391
+17,582
+14% +$987K ﹤0.01% 1049
2022
Q1
$9.28M Sell
125,809
-7,170
-5% -$529K ﹤0.01% 1097
2021
Q4
$9.6M Sell
132,979
-231
-0.2% -$16.7K ﹤0.01% 1143
2021
Q3
$10.2M Sell
133,210
-3,191
-2% -$244K ﹤0.01% 1089
2021
Q2
$10.6M Buy
136,401
+6,437
+5% +$499K ﹤0.01% 1101
2021
Q1
$8.01M Sell
129,964
-7,876
-6% -$486K ﹤0.01% 1152
2020
Q4
$8.99M Buy
137,840
+9,651
+8% +$629K ﹤0.01% 1096
2020
Q3
$6.35M Buy
128,189
+9,418
+8% +$466K ﹤0.01% 1074
2020
Q2
$5.67M Sell
118,771
-9,887
-8% -$472K ﹤0.01% 1070
2020
Q1
$5.47M Sell
128,658
-4,302
-3% -$183K ﹤0.01% 1025
2019
Q4
$7.83M Sell
132,960
-23,938
-15% -$1.41M ﹤0.01% 1032
2019
Q3
$8.02M Buy
156,898
+10,138
+7% +$518K 0.01% 1037
2019
Q2
$6.21M Sell
146,760
-70,991
-33% -$3M ﹤0.01% 1120
2019
Q1
$10.8M Buy
217,751
+2,239
+1% +$111K 0.01% 911
2018
Q4
$9.33M Sell
215,512
-2,830
-1% -$122K 0.01% 897
2018
Q3
$12.4M Sell
218,342
-362
-0.2% -$20.5K 0.01% 877
2018
Q2
$11M Sell
218,704
-2,989
-1% -$151K 0.01% 924
2018
Q1
$11M Sell
221,693
-642
-0.3% -$32K 0.01% 912
2017
Q4
$9.14M Buy
222,335
+15,844
+8% +$651K 0.01% 940
2017
Q3
$6.14M Sell
206,491
-165
-0.1% -$4.9K 0.01% 1019
2017
Q2
$6.85M Buy
206,656
+5,021
+2% +$166K 0.01% 964
2017
Q1
$5.97M Buy
201,635
+46,857
+30% +$1.39M 0.01% 989
2016
Q4
$3.84M Buy
154,778
+30,756
+25% +$763K ﹤0.01% 1052
2016
Q3
$2.8M Buy
124,022
+16,430
+15% +$371K ﹤0.01% 1252
2016
Q2
$2.56M Sell
107,592
-2,925
-3% -$69.7K ﹤0.01% 1265
2016
Q1
$2.63M Buy
110,517
+19,836
+22% +$471K ﹤0.01% 1248
2015
Q4
$2.52M Buy
90,681
+46,820
+107% +$1.3M ﹤0.01% 1336
2015
Q3
$906K Buy
43,861
+10,300
+31% +$213K ﹤0.01% 1762
2015
Q2
$862K Buy
33,561
+12,261
+58% +$315K ﹤0.01% 1750
2015
Q1
$538K Buy
21,300
+900
+4% +$22.7K ﹤0.01% 1941
2014
Q4
$485K Buy
20,400
+1,700
+9% +$40.4K ﹤0.01% 1960
2014
Q3
$368K Hold
18,700
﹤0.01% 2029
2014
Q2
$447K Buy
18,700
+1,100
+6% +$26.3K ﹤0.01% 1956
2014
Q1
$468K Buy
17,600
+100
+0.6% +$2.66K ﹤0.01% 1936
2013
Q4
$353K Buy
17,500
+1,200
+7% +$24.2K ﹤0.01% 2017
2013
Q3
$285K Hold
16,300
﹤0.01% 2117
2013
Q2
$275K Buy
+16,300
New +$275K ﹤0.01% 2044